Homocysteine induced dementia: Collecting evideneces for Alzheimer's disease

International Journal of Pharma and Bio Sciences

Volumn 1, Issue 1, 2010, Pages

  Sharma, Vivek Kumar ^a  

^a Govt College of Pharmacy   (India)

Author keywords

Alzheimer's disease; Dementia; Folic acid; Homocysteine; Memory

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53;

ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; AMINO ACID BRAIN LEVEL; AMINO ACID METABOLISM; ARTICLE; BLOOD BRAIN BARRIER; COGNITIVE DEFECT; DISEASE ASSOCIATION; DNA STRAND BREAKAGE; ENZYME ACTIVATION; HUMAN; HYPERHOMOCYSTEINEMIA; NEUROPATHOLOGY; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTO ONCOGENE; RISK FACTOR;

EID: 82755192214     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. M. Getie, J. Wohlrab, and R. R. H. Neubert. Dermal deliveryz of desmopressin acetate using colloidal carrier systems, J. Pharm. Pharmacol 57 (2): 423-427 (2005).
2. N. Ferlazzo, S. Condello, M. Currò, G. Parisi, R. Ientile and D. Caccamo. NF-kappa B activation is associated with homocysteineinduced injury in Neuro2a cells,BMC Neuroscience 62(9):(2008).
3. J.D. Finkelstein. Methionine metabolism in mammals, J. Nutr. Biochem 1:228 -237(1999).
4. J.M.Scott and D.G. Weir. Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry, J. Cardiovasc Risk 5:223-227(1998).
5. Martin, D. C. (1988). B-12 and folate deficiency dementia. Clinical Geriatric Medicine, 4, 841-852
6. J.J.V.Rodriguez, F. Santolaria, Martinez-Riera, A., Gonzalez-Reimers, E., de la Vega Prieto, M. J., Valls, M. R. A., & Gaspar, M. R. Clinical significance of homocysteine in elderly hospitalized patients. Metabolism Clinical and Experimental 55: 620-627(2006).
7. P.Holford. Alzheimer's and dementia: The nutrition connection, Primary Care Mental Health 2: 5-12(1999).
8. L. Hassing, A. Wahlin,B. Winblad and L. Backman. Further evidence on the effects of vitamin B12 and folate levels on episodic memory functioning: A population-based study of healthy very old adults, Biological Psychiatry 45: 1472-1480(1999).
9. J.W.Miller, M.R.Nadeau,D. Smith and J.Selhub. Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats, American Journal of Clinical Nutrition 59: 1033-1039(1996).
10. G.N.Welch and J. Loscalzo. Homocysteine and atherothrombosis, N Engl J Med 338:1042-1050(1998).
11. R. Surtees, A. Bowron,J. Leonard. Cerebrospinal fluid and plasma total homocysteine and related metabolites in children with cystathionine b-synthase deficiency: the effect of treatment, Pediatr Res 42:577-582(1997).
12. L. Brattstrom, A. Lindgren, B. Israelsson,A. Anderssonand B. Hultberg. Homocysteine and cysteine: determinants of plasma levels in middle aged and elderly subjects, J Intern Med 236:633-641(1994).
13. R.A.Meleady, I.M. Graham. Homocysteine and vascular disease: nature or nurture? J Cardiovasc Risk 5:233-237(1998).
14. R.Clarke,A.D. Smith,K.A. Jobst,H. Refsum,L. Sutton. Folate, vitamin B12, and serum total levels in confirmed Alzheimer disease, Arch Neurol 55:1449-1455(1998).
15. M.A.Mansoor,P.M. Ueland A. Aarsland, A.M. Svardal. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria. Metabolism 42:1481-87(1993).
16. S.R.Lentz. Mechanism of thrombosis in hyperhomocysteinemia. Curr Opin Hematol 5(5):343-52(1998).
17. H. E. Mizrahi, D. W. Jacobsen, and P.Robert. Friedland Plasma Homocysteine: A New Risk Factor for Alzheimer's Disease? IMAJ 4:187-190(2002).
18. W.H. Giles,S.J. Kittner, R.F. Anda,J.B. Croft,M.L. Casper. Serum folate and risk for ischemic stroke. First National Health and Nutrition Examination Survey epidemiologic follow-up study, Stroke 26:1166-1170(1995).
19. V.D. Berg,V.D. Knaap,G.H. Boers,C.D. Stehouwer,J.A. Rauwerda,J. Valk. Hyperhomocysteinaemia; with reference to its neuroradiological aspects, Neuroradiology 37:403-411(1995).
20. C. Isobe,T. Murata,C. Sato, Y.Terayama. Increase of total Homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease, Life Sci 77:1836-1843(2005).
21. A.L.Miller,G.S. Kelly. Homocysteine metabolism: nutritional modulation and impact on health and disease, Altern Med Rev 2:234-254(1997).
22. F.D.Urnov. Methylation and the genome: the power of a small amendment, J Nutr 132:2450-2456(2002).
23. B.T.Zhu. On the mechanism of Homocysteine pathophysiology and pathogenesis: a unifying hypothesis, Histol Histopathol 17:1283-1291(2002).
24. M.P.Mattson,T.B. Shea. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders, Trends Neurosci 26:137-146(2003).
25. S.A.Blaise,E. Nédélec, H.Schroeder,J.M. Alberto,J.L. Guéant,J.L. Daval. Gestational vitamin B deficiency leads to homocysteineassociated brain apoptosis and alters neurobehavioral development in rats, Am J Pathol 170(2):667-679(2007).
26. J.M.Scott, D.G. Weir. Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry, J Cardiovasc Risk 5:223-227(1998).
27. D.G.Savage,J. Lindenbaum,S.P. Stabler,R.H. Allen. Sensitivity of serum methylmalonic acid and total homocysteine determinants for diagnosis of cobalamin and folate deficiencies, Am J Med 96:239-46(1994).
28. G.Thomas, H Guilliams. Homocysteine - A Risk Factor for Vascular Diseases: Guidelines for the Clinical Practice, The Journal of the American Nutraceutical Association 7(1)231-235(2004).
29. O.Nygard,S.E. Vollset,H. Refsum. Total plasma homocysteine and cardiovascular risk profile: the Hordaland homocysteine study, JAMA 274:1526-33(1995).
30. O.Nygard,H.Refsum,P.M. Ueland. Coffee consumption and plasma total homocysteine: the Hordaland homocysteine study, Am J Clin Nutr 65:136-43(1997).
31. M.L.Cravo,L.M. Gloria, J.Selhub. Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status, Am J Clin Nutr 63:220-24(1996).
32. A.G.Bostom,L. Larthrop. Homocysteinemia in end stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes, Kidney Int 52:10-20(1997).
33. I.H.Rosenberg and J.W. Miller. Nutritional factors in physical and cognitive functions of elderly people. American Journal of Clinical Nutrition 55(6): 1237-1243(1992).
34. C.E. Zhang, W. Wei, Y.H. Liu,J.H. Peng, Q. Tian, G.P. Liu, Y. Zhang, and J.Z. Wang. Hyperhomocysteinemia Increases _-Amyloid by Enhancing Expression of _-Secretase and Phosphorylation of Amyloid Precursor Protein in Rat Brain; The American Journal of Pathology 174(4)( 2009).
35. K.A.Jellinger. Alzheimer100-highlights in the history of Alzheimer research, J. Neural Transm 113: 1603-1623(2006).
36. N.Zilka, M.Ferencik,I. Hulin. Neuroinflamation in Alzheimer's disease; protector or promoter, Bratisl Lek Listy, 107(9-10): 374-381(2006).
37. C.P. Ferri, M.Prince,B. Braynec,L. Fratiglioni, M.Ganguli,K. Hall et al. Global prevalence of dementia; a Delphi consensus study, Lancet, 366: 2112-2117(2005).
38. A. Quadros,O.I.weeks,G.A.Ghezala. Role of tau in Alzheimer's dementia and other neurodegenerative diseases, J. Appl. Biomed., 5: 1-12(2007).
39. S.Seshadri et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease, N Engl J Med 346(7):476-483(2002).
40. A.McCaddon,P.Hudson,G. Davies,A Hughes, J.H.Williams. Homocysteine and cognitive decline in healthy elderly, Dement Geriatr Cogn Disord. 12(5):309-313(2001).
41. R.Clarke,A.D. Smith,K.A.Jobst,H. Refsum,L. Sutton,P.M. Ueland. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease, Arch Neurol 55(11):1449-1455(1998).
42. K.J.Pak,S.L. Chan,M.P. Mattson. Homocysteine and folate deficiency sensitize oligodendrocytes to the cell-death-promoting effects of a presenilin-1 mutation and amyloid beta-peptide, Neuromolecular Med 3(2):119-128(2003).
43. A.Lim et al. In vitro and in vivo interactions of homocysteine with human plasma transthretin, J Biol Chem 278(50):49707-49713(2003).
44. M.Lehmann,B. Regland,K. Blennow,C.G.Gottfries. Vitamin B12- B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment, Dement Geriatr Cogn Disord 16(3):145-150(2003).
45. M.L.Bots, L.J.Launer,J. Lindemans,A. Hofman and D.E. Grobbee. Homocysteine, atheroclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam study, Journal of Internal Medicine 242: 339-347(1997).
46. M. Klerk,P. Verhoef, and R. Clarke. MTHFR 677C T Polymorphism and risk of coronary heart disease: A meta-analysis, JAMA 288: 2023-2031(2002).
47. H. Refsum, P.M. Ueland,and & Nygard. Homocysteine and cardiovascular disease, Annual Review of Medicine 49: 31-62(1998).
48. S. Kalmijn,L.J. Launer,J. Lindemans, M.L. Bots, A. Hojman, and M.M. Breteler. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam study, American Journal of Epidemiology, 150: 283-289(1999).
49. T.D. Heijer,S.E. Vermeer,R. Clarke, M. Outkerk,P.J. Koudstaal,A. Hofman et al. Homocysteine and brain atrophy on MRI of non-demented elderly, Brain, 126:170-175(2003).
50. J.H.Williams,E.A.C. Pereira,M.M.Budge and K.M. Bradley. Minimal hippocampal width relates to plasma homocysteine in communitydwelling older people, Age and Ageing, 31:440-444(2002).
51. M.M. Breteler. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective, Neurobiol Aging 21:153-160(2000).
52. A.E.Roher,C. Esh,T.A. Kokjohn,W. Kalbak, D.C.Luhers et al. Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease, Arterioscler Thromb Vasc Biol 23:2055-2062(2003).
53. S.A.Lipton,W.K. KimY.B. Choi et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor, Proc Natl Acad Sci USA 94(11):5923-31(1997).
54. I.Kruman,C. Culmsee,S.L. Chan et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity, J Neurosci 20(18):6920-26(2000).
55. R.Obeid, W.Herrmann. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia, FEBS Lett 580:2994-3005(2006).
56. B.C.Blount, M.M. Mack et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implication for cancer and neuronal damage, Proc Natl Acad Sci USA 94:3290 -3295(1997).
57. A.F.Kamath,A.K. Chauhan,J. Kisucka, V.S. Dole,J. Loscalzo,D.E. Handy,D.D. Wagner. Elevated levels of homocysteine compromise blood brain barrier integrity in mice, Blood 107:591-593(2006).
58. E.Simon,H. Basil et al. Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component, PNAS 106(18)7619-7623(2006).
59. J.M.Kim,H. Lee, N.Chang. Hyperhomocysteinemia due to short-term folate deprivation is related to electron microscopic changes in the rat brain, J Nutr 132:3418-3421(2002).
60. J.C. Torre. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease, Ann N Y Acad Sci 826:75-91(1997).
61. H.Lee,H.J. Kim, J.M. Kim,N. Chang. Effects of dietary folic acid supplementation on cerebrovascular endothelial dysfunction in rats with induced hyperhomocysteinemia, Brain Res 996:139-147(2004).
62. P. Rinaldi et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease, Neurobiol Aging 24(7):915-919(2003).
63. G. Starkebaum,J.M. Harlan. Endothelial cell injury due to coppercatalyzed hydrogen peroxide generation from Homocysteine, J Clin Invest 77:1370 -1376(1986).
64. G.Blundell,B.G. Jones F.A. Rose,N. Tudball. Homocysteine mediated endothelial cell toxicity and its amelioration, Atherosclerosis 122: 163-172(1996).
65. I.Guidi, D. Galimberti et al. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease, Neurobiol Aging 27:262-269(2006).
66. K.P.Loh,S.H. Huang,R. De Silva,B.K. Tan,Y.Z. Zhu. Oxidative stress: apoptosis in neuronal injury, Curr Alzheimer Res 3:327-337(2006).
67. R.F.Huang,S.M. Huang,B.S.Lin,J.S. Wie,T.Z. Liu. Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase-3 activation in HL-60 cells, Life Sci 68:2799-2811(2001).
68. R.F.Huang,S.M. Huang,B.S. Lin, C.Y. Hung,H.T. Lu. N-Acetylcysteine, vitamin C and vitamin E diminish homocysteine thiolactoneinduced apoptosis in human promyeloid HL-60 cells, J Nutr 132:2151-2156(2002).
69. D.Caccamo,A. Campisi,M. Currò,M. Aguennouz,G. Li Volti,R. Avola,R. Ientile. Nuclear factor-kappab activation is associated with glutamate-evoked tissue transglutaminase up-regulation in primary astrocyte cultures, J Neurosci Res 82:858-865(2005).
70. C. Culmsee,M.P. Mattson. p53 in neuronal apoptosis, Biochem Biophys Res Commun 331:761-777(2005).
71. M.H.Jang,S.B. Jung,M.H. Lee,C.J. Kim,Y.T. Oh,I. Kang,J. Kim,E.H. Kim. Melatonin attenuates amyloid beta25-35-induced apoptosis in mouse microglial BV2 cells, Neurosci Lett 380:26-31(2005).
72. S.L.Chan,M.P. Mattson. Caspase and calpain substrates: roles in synaptic plasticity and cell death, J Neurosci Res58:167-190(1999).
73. Z.Q.Liang,Y.L. Li,X.L. Zhao,R. Han,X.X. Wang,Y. Wang,T.N. Chase,M.C. Bennett. NFkappaB contributes to 6-hydroxydopamineinduced apoptosis of nigral dopaminergic neurons through p53, Brain Res 1145:190-203(2007).
74. H.Aleyasin, S.P. Cregan, G.O. Iyirhiaro,M.J. Hare,S.M. Callaghan,R.S. Slack,D.S. Park. Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage, J Neurosci 24:2963-2973(2004).
75. P.Ho, S.C. Collins, S. Dhitavati et al. Homocysteine potentiates b-amyloid neurotoxicity: role of oxidative stress. J Neurochem 78(2):249-53(2001).
76. K.Nishitomi,G. Sakaguchi et al. BACE1 inhibition reduces endogenous abeta and alters APP processing in wild-type mice, J Neurochem 99:1555-1563(2006).
77. N. Iwata,T.C. Saido. Amyloid-beta peptide metabolism and Alzheimer's disease, Nippon Yakurigaku Zasshi 122:5-14(2003).
78. R.Vassar. Beta-secretase, APP, and abeta in Alzheimer's disease, Subcell Biochem 38:79-103(2005).
79. D.J.Selkoe. Alzheimer's disease: a central role for amyloid, J Neuropathol Exp Neurol 53:438-447(1993).
80. M.P.Mattson,K.J. Tomaselli,R.E. Rydel. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF, Brain Res 621:35-49(1993).
81. J.Harada,M. Sugimoto. Activation of caspase-3 in beta-amyloid induced apoptosis of cultured rat cortical neurons, Brain Res 842:311-323(1999).
82. X.Wang,B. Su,S.L. Siedlak,P.I. Moreira,H. Fujioka,Y.Wang,G. Casadesus,X. Zhu. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/ fusion proteins, Proc Natl Acad Sci USA 105:19318-19323(2008).
83. G.Pigino,A. Pelsman,H. Mori,J. Busciglio. Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation, J Neurosci 21:834-842(2001).
84. A. Bernardo,M. McCord,A.M. Troen,J.D. Allison,M.P. McDonald. Impaired spatial memory in APP-overexpressing mice on a homocysteinemia- inducing diet, Neurobiol Aging 28:1195-1205(2007).
85. C.E.Zhang,Q. Tian,W. Wei,J.H. Peng,G.P. Liu,X.W. Zhou,Q. Wang,D.W. Wang,J.Z. Wang. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus, Neurobiol Aging 29:1654-1665(2008).
86. A.J.Levitt,H. Karlinsky H. Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease, Acta Psychiatr Scand 86:301-305(1992).
87. B.Fowler. Homocysteine: overview of biochemistry, molecular biology, and role in disease processes, Semin Vasc Med 5:77-86(2005).
88. B.Hultberg,A. Andersson,A. Isaksson. Hypomethylation as a cause of homocysteineinduced cell damage in human cell lines, Toxicology 147:69-75(2000).